Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy-Reference-Cited by-同舟云学术

Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy

Published:2017-11 Issue:5 Volume:72 Page:712-735
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Schroeck Florian Rudolf,Jacobs Bruce L.,Bhayani Sam B.,Nguyen Paul L.,Penson David,Hu Jim

Publisher

Elsevier BV

Subject

Urology

Reference85 articles.

1. Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse;Jacobs;Health Aff (Millwood),2012

2. Comparative effectiveness of cancer control and survival after robot-assisted versus open radical prostatectomy;Hu;J Urol,2017

3. National trends and determinants of proton therapy use for prostate cancer: a National Cancer Data Base study;Mahal;Cancer,2016

4. Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity;Yu;J Natl Cancer Inst,2013

5. Hospitals look to nuclear tool to fight cancer;Pollack,2007

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimation and determinants of direct hospitalisation cost for coronary heart disease in a low-middle-income country: evidence from a nationwide study in Iranian hospitals;BMJ Open;2024-08

2. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

3. The Oncological and Functional Prognostic Value of Unconventional Histology of Prostate Cancer in Localized Disease Treated with Robotic Radical Prostatectomy: An International Multicenter 5-Year Cohort Study;European Urology Oncology;2024-06

4. Navigating the evolving diagnostic and therapeutic landscape of low- and intermediate-risk prostate cancer;Asian Journal of Andrology;2024-05-03

5. Value‐based payment models and management of newly diagnosed prostate cancer;Cancer Medicine;2023-12-26